Zynerba Pharmaceuticals Reports Fourth Quarter and Year End 2018 Financial Results and Operational Highlights - Nasdaq

Submitted by Anonymous (not verified) on Mon, 03/11/2019 - 06:50

Zynerba Pharmaceuticals Reports Fourth Quarter and Year End 2018 Financial Results and Operational Highlights  NasdaqDEVON, Pa., March 11, 2019-- Zynerba Pharmaceuticals, Inc., the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for.